Case 14
Research Synthesis on One Page
Scenario
Your strategy team has gathered six analyst reports and a set of interview notes about AI adoption in mid-market insurers. You need a short synthesis for an offsite.
Why this framework
Uses PIN: what it's for, the context and source of truth, and a narrow ask. Enough for most everyday work.
Example context
Invented example. Sources on AI adoption among mid-market insurers in the UK and Ireland. Report A (consultancy, 2025, 40 insurers): 55% run at least one generative AI pilot; only 12% in production; main barrier is data quality. Report B (trade body survey, 2025, 85 insurers): 30% in production for claims triage; main barrier is regulatory uncertainty. Report C (academic study, 2024, 18 insurers): adoption is concentrated in customer service chat; skills shortage is the top barrier. Interview notes (six invented interviews with heads of operations): three say vendor lock-in worries them; four say board appetite is cautious; two report cost savings of 'around 10%' in claims handling, unverified; one says staff resistance is low. Sources disagree on production rates and the main barrier.
Prompt
Purpose: Summarise what these sources say about AI adoption among mid-market insurers, for my leadership offsite.
Context: Use only the attached reports and interview notes. Where sources disagree, show the disagreement and name the sources.
Narrow the ask: One page: five key themes, each with supporting sources, then a short list of where the sources disagree and what we still do not know.
Materials (pasted here in place of the attachments):
Invented example. Sources on AI adoption among mid-market insurers in the UK and Ireland. Report A (consultancy, 2025, 40 insurers): 55% run at least one generative AI pilot; only 12% in production; main barrier is data quality. Report B (trade body survey, 2025, 85 insurers): 30% in production for claims triage; main barrier is regulatory uncertainty. Report C (academic study, 2024, 18 insurers): adoption is concentrated in customer service chat; skills shortage is the top barrier. Interview notes (six invented interviews with heads of operations): three say vendor lock-in worries them; four say board appetite is cautious; two report cost savings of 'around 10%' in claims handling, unverified; one says staff resistance is low. Sources disagree on production rates and the main barrier.Example output from ChatGPT
AI Adoption Among Mid-Market Insurers
Leadership Offsite Brief | UK & Ireland | 2024–2025 Evidence
Executive takeaway: [Inference] AI adoption is progressing, but the evidence suggests a gap between experimentation and scaled deployment. Sources disagree on production adoption rates and the biggest obstacles. There is insufficient evidence to establish industry-wide financial returns.
Five key themes
Theme
What the sources tell us
Supporting sources
- Pilots are more common than production deployments
55% report at least one generative AI pilot, but only 12% report production deployment. A separate survey reports 30% production adoption for claims triage.
Report A (2025); Report B (2025)
- Adoption focuses on specific operational use cases
Customer service chat is a concentration area in the academic study. Claims triage is another reported production use case.
Report C (2024); Report B (2025)
- Barriers span technology, regulation and workforce capability
Data quality, regulatory uncertainty and skills shortages are each identified as the leading barrier by different studies.
Reports A, B and C
- Leadership caution and supplier dependence may constrain expansion
Four of six operations leaders describe cautious board appetite; three express concern about vendor lock-in. These interview findings are not necessarily representative.
Interview notes (6 interviews)
- Financial benefits remain insufficiently validated
Two interviewees report claims-handling cost savings of approximately 10%, but these claims are unverified. One reports low staff resistance. Neither finding supports an industry-wide conclusion.
Interview notes
Where the sources disagree
- Production adoption: 12% versus 30%
Report A: 12% in production, within a generative AI adoption survey of 40 insurers.
Report B: 30% in production for claims triage, across 85 insurers.
Interpretation [Inference]: Different definitions, use cases and samples may explain the difference. The figures should not be treated as directly comparable.
- The leading adoption barrier
Report A: Data quality.
Report B: Regulatory uncertainty.
Report C: Skills shortages.
Interpretation [Inference]: AI adoption may face several distinct bottlenecks rather than one universal constraint. The evidence cannot establish their relative importance across the whole market.
- Workforce resistance versus wider organisational caution
Interview notes: One leader reports low staff resistance, while four describe cautious board appetite.
Interpretation [Inference]: Staff acceptance and leadership willingness to invest may differ. These observations are not necessarily contradictory.
What we still do not know
Comparable adoption rates: What proportion of insurers have genuinely scaled AI in production under a consistent definition?
Commercial impact: Are the reported 10% claims-handling savings repeatable, independently measured and net of implementation costs?
Root causes: Which barriers most strongly predict delayed adoption, rather than simply being frequently reported?
Governance and operating model: What controls, skills and supplier arrangements distinguish successful deployments?
Representativeness and change over time: How do adoption patterns vary by insurer size, geography and business line, and what has changed since the 2024–2025 studies?
Leadership discussion
Central question: Are mid-market insurers primarily struggling to adopt AI, or to move from isolated use cases into repeatable, governed and measurable production deployments?
[Inference] The sources make the second explanation worth investigating, but do not establish it conclusively.
Source boundary: Based exclusively on the four supplied, invented source summaries. Report A (n=40), Report B (n=85), Report C (n=18) and six interview notes. No independent validation or external evidence used. Findings should not be presented as verified real-world market statistics.
